Engineered exosome for NIR-triggered drug delivery and superior synergistic chemo-phototherapy in a glioma model
Sign Up to like & getrecommendations! Published in 2020 at "Applied Materials Today"
DOI: 10.1016/j.apmt.2020.100723
Abstract: Abstract Most of chemotherapies are less effective when using alone. Exosomes (Exos) are cell derived nanovesicles that can serve as delivery nanoplatforms. Thus, Exos-based synergistic treatment is emerging as a promising strategy. Nevertheless, it is… read more here.
Keywords: synergistic chemo; delivery; chemo phototherapy; glioma model ... See more keywords
Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model.
Sign Up to like & getrecommendations! Published in 2018 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2018.05.064
Abstract: PURPOSE Temozolomide (TMZ) is the most frequent adjuvant chemotherapy drug in gliomas. PDL1 expresses on various tumors, including gliomas, and anti-PD-1 antibodies have been approved for treating some tumors by FDA. This study was to… read more here.
Keywords: glioma; orthotopic; antibody; group ... See more keywords